ABCC1 and neoplasm: By inhibiting ABCC1 specifically, β-cholanic acid might augment accumulation of doxorubicin in ABCC1-expressing tumours, while retaining ABCB1’s ability to protect sensitive brain tissues to the damaging effects of doxorubicin.